Study: Retratrutide Leads 20% Weight Loss in Diabetes, Heart Patients

Impressive Outcomes from Retatrutide in Clinical Trials In recent phase 3 clinical trials, the highly anticipated drug retatrutide has shown promising results in terms of weight loss and blood sugar management. The drug manufacturer, Eli Lilly, has revealed that the experimental drug has shown up to almost a 23% decrease in starting body weight,…